COLTENE Holding AG

PINK:CLHLF USA Medical Instruments & Supplies
Market Cap
$365.45 Million
Market Cap Rank
#16227 Global
#6273 in USA
Share Price
$61.16
Change (1 day)
+0.00%
52-Week Range
$61.16 - $61.16
All Time High
$127.68
About

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. The company offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curin… Read more

COLTENE Holding AG (CLHLF) - Net Assets

Latest net assets as of June 2025: $90.43 Million USD

Based on the latest financial reports, COLTENE Holding AG (CLHLF) has net assets worth $90.43 Million USD as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($177.22 Million) and total liabilities ($86.79 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $90.43 Million
% of Total Assets 51.03%
Annual Growth Rate 0.78%
5-Year Change 20.57%
10-Year Change 7.11%
Growth Volatility 37.74

COLTENE Holding AG - Net Assets Trend (2004–2024)

This chart illustrates how COLTENE Holding AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for COLTENE Holding AG (2004–2024)

The table below shows the annual net assets of COLTENE Holding AG from 2004 to 2024.

Year Net Assets Change
2024-12-31 $108.80 Million +12.31%
2023-12-31 $96.87 Million -13.65%
2022-12-31 $112.18 Million +4.46%
2021-12-31 $107.40 Million +19.02%
2020-12-31 $90.23 Million -1.07%
2019-12-31 $91.21 Million -69.20%
2018-12-31 $296.17 Million +143.35%
2017-12-31 $121.70 Million +8.42%
2016-12-31 $112.25 Million +10.51%
2015-12-31 $101.58 Million -2.44%
2014-12-31 $104.12 Million +6.62%
2013-12-31 $97.65 Million +0.82%
2012-12-31 $96.86 Million +2.40%
2011-12-31 $94.59 Million -3.33%
2010-12-31 $97.85 Million -11.63%
2009-12-31 $110.73 Million -2.15%
2008-12-31 $113.16 Million -31.69%
2007-12-31 $165.66 Million +11.04%
2006-12-31 $149.20 Million +13.56%
2005-12-31 $131.38 Million +41.05%
2004-12-31 $93.15 Million --

Equity Component Analysis

This analysis shows how different components contribute to COLTENE Holding AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 151.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings $256.95 Million 236.18%
Common Stock $598.00K 0.55%
Other Comprehensive Income $77.14 Million 70.90%
Total Equity $108.80 Million 100.00%

COLTENE Holding AG Competitors by Market Cap

The table below lists competitors of COLTENE Holding AG ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in COLTENE Holding AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 96,874,000 to 108,796,000, a change of 11,922,000 (12.3%).
  • Net income of 20,466,000 contributed positively to equity growth.
  • Dividend payments of 11,946,000 reduced retained earnings.
  • Share repurchases of 123,000 reduced equity.
  • Other comprehensive income decreased equity by 8,527,000.
  • Other factors increased equity by 12,052,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $20.47 Million +18.81%
Dividends Paid $11.95 Million -10.98%
Share Repurchases $123.00K -0.11%
Other Comprehensive Income $-8.53 Million -7.84%
Other Changes $12.05 Million +11.08%
Total Change $- 12.31%

Book Value vs Market Value Analysis

This analysis compares COLTENE Holding AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.36x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 3.09x to 3.36x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 $19.77 $61.16 x
2005-12-31 $28.07 $61.16 x
2006-12-31 $32.15 $61.16 x
2007-12-31 $35.74 $61.16 x
2008-12-31 $24.84 $61.16 x
2009-12-31 $26.69 $61.16 x
2010-12-31 $23.58 $61.16 x
2011-12-31 $22.81 $61.16 x
2012-12-31 $23.12 $61.16 x
2013-12-31 $23.16 $61.16 x
2014-12-31 $24.68 $61.16 x
2015-12-31 $24.09 $61.16 x
2016-12-31 $26.63 $61.16 x
2017-12-31 $28.86 $61.16 x
2018-12-31 $62.83 $61.16 x
2019-12-31 $15.27 $61.16 x
2020-12-31 $15.10 $61.16 x
2021-12-31 $17.97 $61.16 x
2022-12-31 $18.78 $61.16 x
2023-12-31 $16.21 $61.16 x
2024-12-31 $18.21 $61.16 x

Capital Efficiency Dashboard

This dashboard shows how efficiently COLTENE Holding AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 18.81%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 8.18%
  • • Asset Turnover: 1.34x
  • • Equity Multiplier: 1.72x
  • Recent ROE (18.81%) is above the historical average (15.94%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 14.29% 6.08% 0.88x 2.67x $4.00 Million
2005 13.79% 7.34% 0.97x 1.93x $4.99 Million
2006 15.17% 9.06% 1.01x 1.66x $7.72 Million
2007 15.87% 9.59% 1.11x 1.49x $9.73 Million
2008 42.48% 28.88% 1.03x 1.43x $36.75 Million
2009 14.77% 10.80% 0.96x 1.42x $5.28 Million
2010 9.49% 6.05% 0.97x 1.62x $-499.80K
2011 6.33% 4.10% 0.97x 1.58x $-3.47 Million
2012 9.84% 6.03% 1.03x 1.58x $-156.00K
2013 13.51% 8.24% 1.09x 1.50x $3.42 Million
2014 15.01% 9.63% 0.99x 1.58x $5.22 Million
2015 13.13% 8.63% 1.04x 1.47x $3.18 Million
2016 15.38% 10.75% 1.00x 1.43x $6.04 Million
2017 15.66% 11.35% 1.00x 1.37x $6.89 Million
2018 5.03% 7.31% 0.49x 1.42x $-14.71 Million
2019 21.96% 7.32% 1.44x 2.08x $10.91 Million
2020 9.12% 3.31% 1.32x 2.08x $-791.40K
2021 29.52% 11.36% 1.50x 1.74x $20.97 Million
2022 23.18% 9.73% 1.40x 1.70x $14.78 Million
2023 12.33% 4.92% 1.38x 1.81x $2.26 Million
2024 18.81% 8.18% 1.34x 1.72x $9.59 Million

Industry Comparison

This section compares COLTENE Holding AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,683,526,542
  • Average return on equity (ROE) among peers: -32.48%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
COLTENE Holding AG (CLHLF) $90.43 Million 14.29% 0.96x $157.65 Million
ANGELALIGN TECHNOLOGY INC (AGLFF) $480.24 Million 2.52% 0.41x $405.57 Million
Akoya Biosciences Inc (AKYA) $-30.16 Million 0.00% 0.00x $16.24 Million
Alcon AG (ALC) $19.68 Billion 1.70% 0.48x $37.82 Billion
Align Technology Inc (ALGN) $3.85 Billion 10.94% 0.61x $11.75 Billion
AngioDynamics Inc (ANGO) $355.71 Million 3.06% 0.15x $354.40 Million
Ansell Limited (ANSLF) $386.33 Million -0.45% 0.87x $2.58 Billion
AptarGroup Inc (ATR) $2.07 Billion 11.57% 1.03x $8.27 Billion
AtriCure Inc (ATRC) $72.60 Million -15.79% 0.54x $1.42 Billion
Avinger Inc (AVGR) $-35.69 Million 0.00% 0.00x $1.26 Million
Anteris Technologies Global Corp. Common Stock (AVR) $9.03 Million -338.35% 0.77x $156.14 Million